Innovative solutions to the greatest challenges in pharmaceutical development

27 - 29 June 2022

The AGENDA for the 13th Global Drug Delivery & Formulation Summit is now live!

The 2022 Summit covers small molecules and biologicsnew technologies, concepts and case studies in areas such as:

  • Formulation design for poorly soluble compounds
  • The potential of nanotechnology for better deliverability
  • The latest controlled released technologies
  • Improving patient compliance by harnessing data and the latest smart device technology
  • Optimising formulations for continuous manufacturing
  • Overcoming the blood brain barrier and challenges in oral delivery of biologics
  • Reformulation and biosimilars

BOOK FOR €1,495

2022 Speakers

Steve Amoussou-Guenou

Roquette

Global Technical Developer

Sune Andersen

Janssen

Principal Scientist in Particle Engineering

Andreas Liebminger

Takeda

Head of Pharmaceutical Sciences and Devices for PDT R&D

Gavin Andrews

Queen's University Belfast

Professor Vice Dean

Jean-Rene Authelin

Sanofi

Global Head of Pharmaceutical Engineering

Vimalkumar Balasubramanian

Bayer

Senior Scientist/ Science Fellow

Dr. Fatima Bennai-Sanfourche

Bayer

Senior Director of QA & RA Compliance for Medical Devices, Combination products and eHealth

Dr. Andreas Bernkop-Schnürch

Innsbruck University

Head of the Department Center for Chemistry and Biomedicine

Beate Bittner

Roche

Senior Portfolio Strategy Director

Michael Black

Beneo

Head of Sales Pharma

Erik Oude Blenke

AstraZeneca

Associate Principle Scientist

Jeffrey T. Blue

MSD

Executive Director, Vaccine Drug Product Development PR&D

Joshua Boateng

University of Greenwich

Professor in Pharmaceutics and Drug Delivery, School of Science

Luigi Boltri

Adare

Senior Director, Pharmaceutical Sciences

Dr. Stefan Bracht

Bayer

Vice President Head of Drug Delivery Innovation

Dr. Sebastian Braun

LTS Lohmann Therapie-Systeme AG

Head of Formulation Development 1 and Head of Manufacturing MAP

Stephen Buckley

Novo Nordisk

Director, Oral Delivery Technologies

Wenqian Chen

National University of Singapore

Assistant Professor

Ajay Bapurao Chintawar

Pharmathen

Drug Delivery Systems Development Lead

Robin Curtis

University of Manchester

Senior Lecturer

Suha Dadou

Queen’s University Belfast

Research Fellow

Thomas Delacroix

PMC Isochem

R&D Director

Dipen Desai

Amneal Pharmaceuticals

Vice President Formulation & Analytical

Nick DiFranco

Lubrizol Life Science Health

MEM, Global Market Segment Manager for Oral Treatments

Stefanie Dohrn

AbbVie

Principal Scientist

Anja Dörfler

Novartis

Senior Technical Transfer Lead

Dennis Douroumis

University of Greenwich

Professor in Pharmaceutical Technology and Process Engineering

Patrick Duffy

Ashland

R&D Team Leader, Manufacturing Manager for Bioresorbable Polymers

Thomas von Erlach

Vivtex

Co-Founder and Chief Scientific Officer

Dr. Sara Fathollahi

DFE Pharma

Product Application Specialist, Oral Solid Dosage

Paulina Luisa Fischer

AbbVie

PhD Student

Andreas Fischer

Xspray Pharma

Senior Principal Scientist

Nikoletta Fotaki

University of Bath

Reader in (Bio)Pharmaceutics

Gert Fricker

University of Heidelberg

Director at the Institute of Pharmacy and Molecular Biotechnology in the Faculty of Biosciences

Adrian Funke

Bayer

Head of CMC Predictive Development Bayer Science Fellow

Patrick Garidel

Boehringer Ingelheim

Head of Process, Purification and Pharma Development

Joey Glassco

Lubrizol Life Science Health

Senior Global Market Manager for Parenteral Drug Delivery

Dr. Heinrich Haas

BioNTech

Vice President Formulation & Drug Delivery

Pavan Handa

Amneal Pharmaceuticals

Senior Vice President, Specialty Portfolio Management

Vanessa Havenith

SE Tylose GmbH & Co. KG

Technical Sales Manager

Philipp Hebestreit

BASF

Regional Technical Service Manager

Martin Huelsmeyer

AbbVie

Head of Science Affairs & Strategic Initiatives, NBE Formulation Sciences, Senior Principal Research Scientist

James Humphrey

Croda Pharma

Research & Technology Specialist

Ajay J. Khopade

Sun Pharma Advanced Research

Vice President-R&D, Formulation Development (Non-Orals)

Sebastian Kube

Boehringer Ingelheim

Senior Data Scientist

Samuel Kyeremateng

Abbvie

Principal Scientist

Dimitrios Lamprou

Queen’s University Belfast

Professor & MSc Director

Corentin Larcy

UCB

NCE Drug Product Expert

Robert W. Lee

Lubrizol Life Science Health

President of the CDMO Division

Andrew Lewis

Quotient Sciences

Vice President, Pharmaceutical Sciences

Philippe Lienard

Pasteur Institute

Pre-Clinical Leader

Lorenzo Gentiluomo

Lonza

Associate Principal Scientist

Christian Lotz

Pfanstiehl GmbH

General Manager EMEA

Dr Fiona MacDougall

BDD

Director of Biopharmaceutics

Dr. Manfred Ogris

University of Vienna

Professor Department of Pharmaceutical Sciences

Tatiana Marcozzi

Janssen

Senior Scientist – Oral Solid Development

Lena Mareczek

Merck KGaA

Scientist

Melanie Marota

MSD

Principal Scientist

Heinrich Martens

Fresenius Kabi

Vice President Regulatory Affairs - BU Devices Pharmaceuticals and Devices Division

Dr. Chris McConville

Extruded Pharmaceuticals Ltd

Chief Scientific Officer

Tiffany  McIntire

Roche

Principal Human Factors Engineer, Pharma Technical Development Biologics Europe Device and Packaging Development

Salvatore Mercuri

Lonza

Associate Director, NPI & MSAT, Monteggio

Mikolaj Milewski

MSD

Principal Scientist

Valentyn Mohylyuk

Queen's University Belfast

Pharmaceutical Scientist (research fellow)

Mostafa Nakach

Sanofi

Head of formulation and Process Development

Rene Van Nostrum

Utrecht University

Associate Professor, Pharmaceutical Sciences

Christoph Nüboldt

Invite-GmbH

Scientist 

Ravi Pamnani

Intact Therapeutics

CEO

Mark Parry

Intertek Melbourn

Technical Director

Alexandre Gil , Ph.D.

WuXi STA

SVP, Pharmaceutical Development Services

Kishore Ravuri

Roche

Pharmaceutical Development & Supplies, PTD Biologics Europe (PTDE-P)

Frank Van Reeth

Novartis

Director Ophta and IHD Device Portfolio, Global Device & Packaging Development (GDPD) in TRD

Dr. Angela Lopez del Rio

Boehringer Ingelheim

Scientist    

Gabriele Sadowski

TU Dortmund University

Professor Laboratory for Thermodynamics

Imad Sallit

Novartis

Senior Technical Steward Devices MS&T Steriles

Ana Gomes dos Santos

AstraZeneca

Principal Scientist

Christian Schneider

Celanese Corp

New Business Development Manager

Harshal Shah

Cambridge Consultants

Head of Global BioPharma Commercial

John C. Shelley

Schrödinger

Fellow

Dunja Šilić

Pliva

Senior Product Development Scientist

Soren Skov

Novartis

Senior Expert Human Factors / User Experience

Corinna Sonderegger

Novartis

Executive Director Competence Center, Global Device & Packaging Development (GDPD)

Beat U. Steffen

confinis ag

Founder & CEO

Sven Stegemann

Graz University of Technology

Professor

Christophe Tistaert

Janssen

Principal Scientist

Vivek Trivedi

University of Kent

Lecturer in Drug Delivery, Medway School of Pharmacy

Professor Ijeoma F. Uchegbu

UCL School of Pharmacy

Chair in Pharmaceutical Nanoscience

Shahid Uddin

Immunocore

Director of Formulation & Stability

Driton Vllasaliu

King’s College London

Senior Lecturer in Pharmaceutics

Matthias Gerhard Wacker

National University of Singapore

Associate Professor

Leonie Wagner

Roche

Formulation Scientist

×

Latest News

Nanoform’s Clinical Study Indicates Positive Interim Results

Helsinki, Finland – Nanoform Finland Plc (“Nanoform”), an innovative nanoparticle medicine enabling company, today announced positive interim results from its clinical study. The faster absorption data implies that small particles can indeed be powerful.

Silicones for drug infusion devices - From hospital to wearable: how silicones are used at different scales to help patients live a normal life

This e-book presents an overview of the medical, industrial, compliance and economic advantages and challenges in the use of silicone materials in Infusion as a method of drug delivery. The unique properties of silicones along with their longstanding, proven track record in medical applications, can enable innovative solutions that improve the quality and efficacy of infusion care.

PMC Isochem To accelerate Polyamino acids Business as part of ISODEL® Drug Delivery offer, a unique One Stop Shop for NCA and PAA

PMC Isochem announces today that it is accelerating the strategic development and manufacture of polyamino acids (PAA) as functional excipients used in complex formulations and drug delivery solutions. Based on its own internal resources and endowed with a fully integrated know-how as well as its leading position in the manufacture of critical Activated Amino Acids (NCA), PMC Isochem becomes the reliable supplier of PAA and the sustainable partner.